The NVRL will replace its current HCV genotyping assay - the Siemens Versant HCV genotyping v2.0 (Lipa)- with the Abbott RealTime HCV GT-11 assay in July 2011.
The Abbott RealTime HCV GT-II is a CE marked automated real time RT-PCR assay designed to determine genotype in HCV infected individuals. The system distinguishes between genotypes 1-6 with an estimated sensitivity of 5001U/ml. The system offers a number of analytical and procedural advantages over the current assay resulting in an anticipated reduction in result turnaround time.
